Effect of tumor necrosis factor alpha on mitogen-activated human B cells

doi:10.1084/jem.166.3.786

This Article

	Full Text (PDF, 359K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kehrl, J. H.
	Articles by Fauci, A. S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kehrl, J. H.
	Articles by Fauci, A. S.


Social Bookmarking

	What's this?

ARTICLES

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

JH Kehrl, A Miller and AS Fauci

In this study we demonstrate that the monocyte/macrophage product, tumor necrosis factor alpha (TNF-alpha), has significant in vitro effects of B cell function. It costimulated with anti-mu in the induction of B cell DNA synthesis, and it prolonged the DNA synthesis initiated in B cell cultures stimulated with the human B cell mitogen, Staphylococcus aureus Cowan strain I (SAC). The addition of either IL-1 or IFN-gamma to TNF-alpha resulted in a substantial further increase in DNA synthesis. The addition of TNF-alpha to IL-2, a known inducer of SAC-activated B cell Ig secretion, resulted in a twofold enhancement in the amount of IL-2 stimulated B cell Ig secretion. Receptor binding studies with 125I-TNF-alpha demonstrate a marked increase in TNF-alpha binding sites after B cell activation (approximately 6,000 sites per cell, with an apparent Kd of 2.0 X 10(-10) M). Thus, TNF-alpha may be an important factor in human B cell function and is likely to interact with other T cell and monocyte derived cytokines in the regulation of human B cell proliferation and Ig production.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Emonts, M., Veenhoven, R. H., Wiertsema, S. P., Houwing-Duistermaat, J. J., Walraven, V., Groot, R. d., Hermans, P. W.M., Sanders, E. A.M. (2007). Genetic Polymorphisms in Immunoresponse Genes TNFA, IL6, IL10, and TLR4 Are Associated With Recurrent Acute Otitis Media. Pediatrics 120: 814-823 [Abstract] [Full Text]
Aspalter, R. M., Eibl, M. M., Wolf, H. M. (2003). Regulation of TCR-mediated T cell activation by TNF-RII. J. Leukoc. Biol. 74: 572-582 [Abstract] [Full Text]
Fox, D. A. (2000). Cytokine Blockade as a New Strategy to Treat Rheumatoid Arthritis: Inhibition of Tumor Necrosis Factor. Arch Intern Med 160: 437-444 [Abstract] [Full Text]
Skeie, G. O., Pandey, J. P., Aarli, J. A., Gilhus, N. E. (1999). TNFA and TNFB Polymorphisms in Myasthenia Gravis. Arch Neurol 56: 457-461 [Abstract] [Full Text]
Ebert, E C (1998). Tumour necrosis factor-alpha enhances intraepithelial lymphocyte proliferation and migration. Gut 42: 650-655 [Abstract] [Full Text]
Rankin, E., Isenberg, D. (1997). IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus 6: 390-394 [Abstract]
Jakobs, D.M., Schade, F.U. (1994). Regulation of endotoxin mitogenicity in murine spleen cells by tumor necrosis factor {alpha}. Innate Immunity 1: 175-179 [Abstract]